Vectura Group PLC’s (VEC) Buy Rating Reiterated at Numis Securities Ltd
Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reiterated by equities researchers at Numis Securities Ltd in a research note issued to investors on Tuesday. They presently have a GBX 246 ($3.28) price target on the stock. Numis Securities Ltd’s price target indicates a potential upside of 78.91% from the company’s previous close.
A number of other research analysts have also commented on the stock. Stifel Nicolaus restated a “buy” rating and set a GBX 250 ($3.33) price target on shares of Vectura Group PLC in a research report on Thursday, May 26th. Peel Hunt restated a “buy” rating and set a GBX 200 ($2.66) price target on shares of Vectura Group PLC in a research report on Friday, August 5th. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 230 ($3.06) price target on shares of Vectura Group PLC in a research report on Thursday, July 28th. Finally, FinnCap restated a “buy” rating and set a GBX 225 ($3.00) price target on shares of Vectura Group PLC in a research report on Tuesday, August 30th. Eight investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and an average price target of GBX 221.50 ($2.95).
Vectura Group PLC (LON:VEC) traded down 4.25% during mid-day trading on Tuesday, reaching GBX 137.50. The company had a trading volume of 1,698,337 shares. Vectura Group PLC has a 12-month low of GBX 122.90 and a 12-month high of GBX 200.10. The firm’s market capitalization is GBX 564.60 million. The firm has a 50-day moving average price of GBX 142.78 and a 200 day moving average price of GBX 157.64.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/10/vectura-group-plcs-vec-buy-rating-reiterated-at-numis-securities-ltd.html
In other Vectura Group PLC news, insider Derodra,Andrew sold 419,661 shares of the business’s stock in a transaction on Friday, June 17th. The shares were sold at an average price of GBX 154 ($2.05), for a total value of £646,277.94 ($860,785.75).
About Vectura Group PLC
Vectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies.
Receive News & Ratings for Vectura Group PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Vectura Group PLC and related companies with MarketBeat.com’s FREE daily email newsletter.